221 related articles for article (PubMed ID: 17018382)
1. Liver expression of hepcidin and other iron genes in two mouse models of beta-thalassemia.
De Franceschi L; Daraio F; Filippini A; Carturan S; Muchitsch EM; Roetto A; Camaschella C
Haematologica; 2006 Oct; 91(10):1336-42. PubMed ID: 17018382
[TBL] [Abstract][Full Text] [Related]
2. An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe(-/-) mice and ameliorates anemia and iron overload in murine β-thalassemia intermedia.
Schmidt PJ; Toudjarska I; Sendamarai AK; Racie T; Milstein S; Bettencourt BR; Hettinger J; Bumcrot D; Fleming MD
Blood; 2013 Feb; 121(7):1200-8. PubMed ID: 23223430
[TBL] [Abstract][Full Text] [Related]
3. mRNA expression of iron regulatory genes in beta-thalassemia intermedia and beta-thalassemia major mouse models.
Weizer-Stern O; Adamsky K; Amariglio N; Rachmilewitz E; Breda L; Rivella S; Rechavi G
Am J Hematol; 2006 Jul; 81(7):479-83. PubMed ID: 16755567
[TBL] [Abstract][Full Text] [Related]
4. Hepcidin levels and iron status in beta-thalassemia major patients with hepatitis C virus infection.
Hendy OM; Allam M; Allam A; Attia MH; El Taher S; Eldin MM; Ali A
Egypt J Immunol; 2010; 17(2):33-44. PubMed ID: 23082485
[TBL] [Abstract][Full Text] [Related]
5. A competitive enzyme-linked immunosorbent assay specific for murine hepcidin-1: correlation with hepatic mRNA expression in established and novel models of dysregulated iron homeostasis.
Gutschow P; Schmidt PJ; Han H; Ostland V; Bartnikas TB; Pettiglio MA; Herrera C; Butler JS; Nemeth E; Ganz T; Fleming MD; Westerman M
Haematologica; 2015 Feb; 100(2):167-77. PubMed ID: 25425686
[TBL] [Abstract][Full Text] [Related]
6. Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of β-thalassemia.
Kautz L; Jung G; Du X; Gabayan V; Chapman J; Nasoff M; Nemeth E; Ganz T
Blood; 2015 Oct; 126(17):2031-7. PubMed ID: 26276665
[TBL] [Abstract][Full Text] [Related]
7. Liver iron concentrations and urinary hepcidin in beta-thalassemia.
Origa R; Galanello R; Ganz T; Giagu N; Maccioni L; Faa G; Nemeth E
Haematologica; 2007 May; 92(5):583-8. PubMed ID: 17488680
[TBL] [Abstract][Full Text] [Related]
8. Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice.
Gardenghi S; Ramos P; Marongiu MF; Melchiori L; Breda L; Guy E; Muirhead K; Rao N; Roy CN; Andrews NC; Nemeth E; Follenzi A; An X; Mohandas N; Ginzburg Y; Rachmilewitz EA; Giardina PJ; Grady RW; Rivella S
J Clin Invest; 2010 Dec; 120(12):4466-77. PubMed ID: 21099112
[TBL] [Abstract][Full Text] [Related]
9. Deletion of TMPRSS6 attenuates the phenotype in a mouse model of β-thalassemia.
Nai A; Pagani A; Mandelli G; Lidonnici MR; Silvestri L; Ferrari G; Camaschella C
Blood; 2012 May; 119(21):5021-9. PubMed ID: 22490684
[TBL] [Abstract][Full Text] [Related]
10. Hepcidin and Hfe in iron overload in beta-thalassemia.
Gardenghi S; Ramos P; Follenzi A; Rao N; Rachmilewitz EA; Giardina PJ; Grady RW; Rivella S
Ann N Y Acad Sci; 2010 Aug; 1202():221-5. PubMed ID: 20712796
[TBL] [Abstract][Full Text] [Related]
11. First phenotypic description of transferrin receptor 2 knockout mouse, and the role of hepcidin.
Wallace DF; Summerville L; Lusby PE; Subramaniam VN
Gut; 2005 Jul; 54(7):980-6. PubMed ID: 15951546
[TBL] [Abstract][Full Text] [Related]
12. Exogenous iron increases hemoglobin in beta-thalassemic mice.
Ginzburg YZ; Rybicki AC; Suzuka SM; Hall CB; Breuer W; Cabantchik ZI; Bouhassira EE; Fabry ME; Nagel RL
Exp Hematol; 2009 Feb; 37(2):172-83. PubMed ID: 19059700
[TBL] [Abstract][Full Text] [Related]
13. Regulation of iron homeostasis by hepatocyte TfR1 requires HFE and contributes to hepcidin suppression in β-thalassemia.
Xiao X; Moschetta GA; Xu Y; Fisher AL; Alfaro-Magallanes VM; Dev S; Wang CY; Babitt JL
Blood; 2023 Jan; 141(4):422-432. PubMed ID: 36322932
[TBL] [Abstract][Full Text] [Related]
14. Effects of alcohol consumption on iron metabolism in mice with hemochromatosis mutations.
Flanagan JM; Peng H; Beutler E
Alcohol Clin Exp Res; 2007 Jan; 31(1):138-43. PubMed ID: 17207112
[TBL] [Abstract][Full Text] [Related]
15. Combined deletion of Hfe and transferrin receptor 2 in mice leads to marked dysregulation of hepcidin and iron overload.
Wallace DF; Summerville L; Crampton EM; Frazer DM; Anderson GJ; Subramaniam VN
Hepatology; 2009 Dec; 50(6):1992-2000. PubMed ID: 19824072
[TBL] [Abstract][Full Text] [Related]
16. Global loss of Tfr2 with concomitant induced iron deficiency greatly ameliorates the phenotype of a murine thalassemia intermedia model.
Schmidt PJ; Fitzgerald K; Butler JS; Fleming MD
Am J Hematol; 2021 Feb; 96(2):251-257. PubMed ID: 33180328
[TBL] [Abstract][Full Text] [Related]
17. Decreased hepcidin expression in murine β-thalassemia is associated with suppression of Bmp/Smad signaling.
Parrow NL; Gardenghi S; Ramos P; Casu C; Grady RW; Anderson ER; Shah YM; Li H; Ginzburg YZ; Fleming RE; Rivella S
Blood; 2012 Mar; 119(13):3187-9. PubMed ID: 22461476
[No Abstract] [Full Text] [Related]
18. Hepatic expression of hemochromatosis genes in two mouse strains after phlebotomy and iron overload.
Bondi A; Valentino P; Daraio F; Porporato P; Gramaglia E; Carturan S; Gottardi E; Camaschella C; Roetto A
Haematologica; 2005 Sep; 90(9):1161-7. PubMed ID: 16154838
[TBL] [Abstract][Full Text] [Related]
19. Anemia in beta-thalassemia patients targets hepatic hepcidin transcript levels independently of iron metabolism genes controlling hepcidin expression.
Camberlein E; Zanninelli G; Détivaud L; Lizzi AR; Sorrentino F; Vacquer S; Troadec MB; Angelucci E; Abgueguen E; Loréal O; Cianciulli P; Lai ME; Brissot P
Haematologica; 2008 Jan; 93(1):111-5. PubMed ID: 18166793
[TBL] [Abstract][Full Text] [Related]
20. Transgenic HFE-dependent induction of hepcidin in mice does not require transferrin receptor-2.
Schmidt PJ; Fleming MD
Am J Hematol; 2012 Jun; 87(6):588-95. PubMed ID: 22460705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
